Activities of vitamin Q10 in animal models and a serious deficiency in patients with cancer.
New data on blood levels of vitamin Q10 in 116 cancer patients reveal an incidence of 23.1% of patients (N=17) with breast cancer whose blood levels were below 0.5 microg/ml. The incidence of breast cancer cases with levels below 0.6 microg/ml was 38.5%. The incidence is higher (p<0.05) than that for a group of ordinary people. Patients (N=15) with myeloma showed a mean blood level of 0.67 +/- 0.17 microg/ml. The incidence of a vitamin Q10 blood level below 0.7 microg/ml for these 15 cases of myeloma was 53.3%, which is higher (p<0.05) than the 24.5% found for a group of ordinary people.
Folkers
K
K
Institute for Biomedical Research, University of Texas at Austin, 78712, USA.
Osterborg
A
A
Nylander
M
M
Morita
M
M
Mellstedt
H
H
D000818:Animals; D001943:Breast Neoplasms / Q000097:blood; D003067:Coenzymes; D005260:Female; D006801:Humans; D008297:Male; D009101:Multiple Myeloma / Q000097:blood; D009369:Neoplasms / Q000097:blood*; D009374:Neoplasms, Experimental / Q000097:blood; D012016:Reference Values; D014451:Ubiquinone / Q000031:analogs & derivatives* / Q000097:blood / Q000378:metabolism
D003067:Coenzymes; D014451:Ubiquinone; C024989:coenzyme Q10